ViiV, Pfizer and Roche lead list for pharma reputation ranked by patient group, annual survey finds
Patient groups’ view of the pharma industry around the world is improving, according to an annual survey published on Tuesday. Fifty-nine percent of patient groups …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
